Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Clinical trial NCT07284459 · RECRUITING
Trial details
- NCT number
- NCT07284459
- Sponsor
- Contineum Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-08
- Primary completion
- 2028-05-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.